Prilenia: IROS, Prilenia and IHA team up for Huntington's disease trial

Abu Dhabi-based contract research organisation and a part of the M42 group, IROS has announced a collaboration with Prilenia Therapeutics and the International Huntington's Disease Association (IHA) to conduct a clinical trial for Huntington's disease (HD) in the UAE and MENA region. The post IROS, Prilenia and IHA team up for Huntington's disease trial appeared first on Clinical Trials Arena.